Evidence map›Paper›PMID 31822798›Full record

ArticleOncogene2020

Disease-specific alteration of karyopherin-α subtype establishes feed-forward oncogenic signaling in head and neck squamous cell carcinoma.

Masaharu Hazawa, Kie Sakai, Akiko Kobayashi, Hironori Yoshino, Yoshihiro Iga, Yuki Iwashima, Kee Sing Lim, Dominic Chih-Cheng Voon, Yan-Yi Jiang, Shin-Ichi Horike and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Nuclear transport proteins: structure, function, and disease relevance.Signal transduction and targeted therapy · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Germline risk of clonal haematopoiesis.Nature reviews. Genetics · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Masaharu HazawaCell-Bionomics Research Unit, Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Ishikawa, Japan. masaharu.akj@gmail.com.
Kie SakaiCell-Bionomics Research Unit, Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Ishikawa, Japan.
Akiko KobayashiWPI Nano Life Science Institute, Kanazawa University, Kanazawa, Ishikawa, Japan.
Hironori YoshinoDepartment of Radiation Science, Hirosaki University Graduate School of Health Sciences, 66-1 Hon-cho, Hirosaki, Aomori, 036-8564, Japan.ORCID http://orcid.org/0000-0003-2705-9929
Yoshihiro IgaLaboratory of Molecular Cell Biology, School of Natural System, Institute of Science and Engineering, Kanazawa University, Kanazawa, Ishikawa, Japan.
Yuki IwashimaLaboratory of Molecular Cell Biology, School of Natural System, Institute of Science and Engineering, Kanazawa University, Kanazawa, Ishikawa, Japan.
Kee Sing LimWPI Nano Life Science Institute, Kanazawa University, Kanazawa, Ishikawa, Japan.
Dominic Chih-Cheng VoonCancer Model Research Innovative Unit, Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Japan.
Yan-Yi JiangDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Shin-Ichi HorikeCell-Bionomics Research Unit, Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Ishikawa, Japan.
De-Chen LinDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Richard W WongCell-Bionomics Research Unit, Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Ishikawa, Japan. rwong@staff.kanazawa-u.ac.jp.ORCID http://orcid.org/0000-0002-2131-6595
Kanazawa University · JPCedars-Sinai Medical Center · USHirosaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear import, mediated in part by karyopherin-α (KPNA)/importin-α subtypes, regulates transcription factor access to the genome and determines cell fate. However, the cancer-specific changes of KPNA subtypes and the relevancy in cancer biology remain largely unknown. Here, we report that KPNA4, encoding karyopherin-α4 (KPNA4), is exclusively amplified and overexpressed in head and neck of squamous cell carcinoma (HNSCC). Depletion of KPNA4 attenuated nuclear localization signal-dependent transport activity and suppressed malignant phenotypes and induced epidermal differentiation. Mechanistically, KPNA4-mediated nuclear transport of Ras-responsive element-binding protein (RREB1), which sustains Ras/ERK pathway signaling through repressing miR-143/145 expression. Notably, MAPK signaling enhanced trafficking activity of KPNA4 via phosphorylation of KPNA4 at Ser60. These data reveal that KPNA4 establishes a feed-forward cascade that potentiates Ras/ERK signaling in HNSCC.

Indexed as

CarcinogenesisGene AmplificationActive Transport, Cell Nucleusalpha KaryopherinsAmino Acid SequenceCell Line, TumorDNA-Binding ProteinsGene Expression Regulation, NeoplasticHEK293 CellsHumansMicroRNAsNuclear Localization SignalsPhosphorylationProtein Processing, Post-TranslationalProtein TransportSequence Alignmentalpha KaryopherinsDNA-Binding ProteinsKPNA4 protein, humanMicroRNAsMIRN143 microRNA, humanMIRN145 microRNA, humanNuclear Localization SignalsRREB1 protein, humanTranscription Factors

Identifiers

PMID31822798
PMCPMC7056645
OpenAlexW2995749259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.